Examining the Impact of Antimicrobial Fluoroquinolones on Human DNA Topoisomerase IIα and IIβ.

Author: DeweeseJoseph E, FiefCole A, HoangKristine G, PhippsStephen D, WallaceJessica L

Paper Details 
Original Abstract of the Article :
Fluoroquinolones are a class of widely prescribed antibiotics with a broad range of activity against Gram-positive, Gram-negative, and some atypical microbes. Unfortunately, these drugs are associated with significant adverse events including neuropathy, tendinopathy, cardiac rhythm abnormalities, a...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6648947/

データ提供:米国国立医学図書館(NLM)

Fluoroquinolones and Human Topoisomerase II: A Closer Look at the Interaction

Fluoroquinolones, a widely prescribed class of antibiotics, are known for their broad-spectrum antibacterial activity. However, their use is associated with a range of side effects, including neuropathy, tendinopathy, and cardiac rhythm abnormalities. The mechanisms underlying these toxicities remain unclear, prompting researchers to investigate the potential role of human topoisomerase II, a key enzyme involved in DNA replication and repair.

The researchers examined the effects of several fluoroquinolones on human topoisomerase IIα and IIβ. They discovered that while these antibiotics did inhibit the ability of the enzyme to relax DNA at high concentrations, these concentrations were significantly higher than those typically achieved in patients. Importantly, they found no evidence that the fluoroquinolones tested could induce DNA cleavage by these enzymes. These findings suggest that human topoisomerase II is unlikely to be a primary target for the adverse events associated with fluoroquinolone use. Further research is needed to identify other potential mechanisms of toxicity.

A New Direction in Understanding Fluoroquinolone Toxicity

This study sheds light on the complex interactions between fluoroquinolones and human topoisomerase II. The lack of evidence for DNA cleavage by these enzymes at clinically relevant concentrations suggests that other targets may be responsible for the observed adverse events. This finding opens new avenues for investigating the mechanisms of fluoroquinolone toxicity.

Navigating the Risks and Benefits of Antibiotics

This study serves as a reminder that even widely used antibiotics can have complex and sometimes unexpected effects. It underscores the importance of carefully evaluating the potential risks and benefits of antibiotics, especially when long-term use is considered.

Dr.Camel's Conclusion

Just like a camel navigating a treacherous desert, understanding the effects of medications requires a keen eye and meticulous exploration. This study reminds us that the journey of scientific discovery continues, uncovering new insights into the intricate mechanisms of drug action and paving the way for safer and more effective therapies.

Date :
  1. Date Completed n.d.
  2. Date Revised 2020-10-01
Further Info :

Pubmed ID

31459613

DOI: Digital Object Identifier

PMC6648947

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.